MedRX (4586) Earnings Report: Revenue Decreases 37.7% YoY with Operating Loss of 544 Million Yen

MedRX (4586) has released its financial results, reporting revenue of 11 million yen, representing a 37.7% decrease compared to the same period of the previous year. On the profit front, the company posted an operating loss of 544 million yen, an ordinary loss of 554 million yen, and a net loss attributable to owners of the parent of 551 million yen. Earnings per share (EPS) stood at -9.27 yen.

From a financial and valuation perspective, the company maintains cash and cash equivalents of 1.14 billion yen. Meanwhile, return on equity (ROE) stands at -49.06% and return on assets (ROA) at -43.45%. the sum of operating profit and depreciation expense for the six months ended June 30, 2026 was approximately -538.98 million yen (reference calculation; source: financial results), operating cash flow for the six months ended June 30, 2026 was approximately -661.45 million yen, and the sum of operating and investing cash flows was approximately -664.64 million yen (reference calculation). While profitability remains a near-term challenge, the company's cash position underpins its financial stability as it pursues future growth and monetization.

---

Correction (September 19, 2026)：The affected figures and reporting-period labels were corrected after checking the source disclosure. Source disclosure